Decoding cardiotoxicity through proteomics and metabolomics: cathepsin C and amino acids take centre stage

European Heart Journal 2026

View at publisher
Authors: Giulia Guerra, Alessandra Ghigo
DOI: 10.1093/eurheartj/ehag507
Cited by: 1
References: 14

Abstract

This editorial refers to ‘Cardiac remodelling and dysfunction in cancer patients receiving cardiotoxic therapies: proteomic and metabolomic profiling’, by

Fields of Study & Subjects

Metabolomics and Mass Spectrometry Studies Protease and Inhibitor Mechanisms Mitochondrial Function and Pathology

Publication details

Journal / source
European Heart Journal
Publisher
Oxford University Press (OUP)
Volume
47
Issue
35
Pages
5026–5028
Publication date
9 July 2026
Language
EN